Status:
WITHDRAWN
SCD Fit Homebase Program
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Cardiovascular Diseases
Sickle Cell Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this project is to develop novel approaches to promote health and longevity while enhancing quality of life among persons with Sickle cell disease (SCD). Therefore, investigators are ai...
Detailed Description
Sickle cell disease (SCD) is a major public health concern as it is the most common inherited blood disorder in the US, affecting predominantly African Americans.1 SCD causes intermittent painful vaso...
Eligibility Criteria
Inclusion
- Eligible participants will include ambulatory adult patients of all SCD genotypes who are in care at UAB's sickle cell center and provide consent to participate in the study.
- Eligible participants include adults with SCD of any genotype older than 18 yrs. of age followed by the UAB sickle cell center.
- Participants must be in steady-state disease defined as not having a vaso-occlusive crisis or SCD-related hospitalization within four weeks of enrollment.
Exclusion
- Participants will be excluded if they have severe avascular necrosis of the hip, are pregnant, or have absolute contraindications to exercise according to the American Heart Association (AHA) and American College of Sports Medicine guidelines
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05228756
Start Date
November 1 2022
End Date
December 1 2023
Last Update
October 19 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.